Klaus Frobel

This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1987-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Frobel. Retrieved from https://idiyas.com/inventor/klaus-frobel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

8 out of 12,268

Bayer Aktiengesellschaft

patents

Years Active: 1987-1996

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5492896 - Pseudopeptides having an antiviral action (1996-02-20),

2. 5190971 - Substituted dibenz-oxa-thiocinones, -12-oxides and -12,12-dioxides, a (1993-03-02),

3. 5185326 - Efomycins A, E and G as antiinflammatory agents (1993-02-09),

4. 5089487 - Circulation-active dibenzo[1,5]dioxocin-5-ones (1992-02-18),

5. 5073369 - Efomycins as performance promoters in animals (1991-12-17),

6. 4927810 - Efomycin G and it's use as yield promoter in animals (1990-05-22),

7. 4770876 - Microbiological production of livestock growth-promoting agent (1988-09-13),

8. 4670260 - Antibiotic for animal feeds (1987-06-02),

Title: The Innovative Journey of Klaus Frobel: Pioneering Inventor from Wuppertal

Introduction:

Klaus Frobel, a visionary inventor hailing from Wuppertal, Germany, has made significant strides in the realm of innovations with his relentless pursuit of creating groundbreaking technologies. His dedication to pushing the boundaries of conventional thinking has established him as a trailblazer in the world of inventions.

Latest Patents:

Frobel's recent patents include 'Pseudopeptides having an antiviral action' and 'Substituted dibenz-oxa-thiocinones, -12-oxides and -12,12-dioxides.' These inventions showcase his prowess in developing novel solutions to combat viral infections and advance the field of medicaments.

Career Highlights:

With an impressive portfolio of 8 patents to his name, Klaus Frobel has demonstrated a remarkable commitment to innovation. His work at Bayer Aktiengesellschaft has further solidified his reputation as a leading figure in the pursuit of technological advancements.

Collaborations:

Frobel's collaborative efforts with esteemed colleagues such as Hartwig Muller and Erwin Bischoff have led to synergistic innovation and the development of cutting-edge inventions. Through teamwork and shared expertise, they have collectively contributed to the advancement of science and technology.

Conclusion:

In conclusion, Klaus Frobel's remarkable journey as an inventor underscores his unwavering passion for innovation and his tireless efforts to shape a better future through technology. His inventive spirit continues to inspire aspiring inventors to think boldly and pursue their creative visions, leaving a lasting impact on the world of inventions.

Profile summary based on public USPTO records.